causal

Innovation-Reward-Competition Cycle Is Distorted

The intended drug system—innovation, reward, then competition driving prices down—has been distorted into innovation, reward, more reward, and less-valuable innovation, because the large development costs (often cited as a billion dollars) apply only to genuinely new drugs (under 20% of the market) while the other 80% are recycled existing drugs that don't carry those costs and aren't the innovation society wants.

causalpending

Speaker

Robin Feldman

Evidence Quote

“those large numbers of how much it costs to develop a new drug: Those are for the new drugs. For what's probably less than 20% of the market... But, 80% of what we've got out there don't have those costs.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...